Menu
Recruiting NCT07331753

The Outcomes of Fat Grafting Combined With Latissimus Dorsi Muscle Flap for Delayed Breast Reconstruction After Mastectomy

No phase Interventional Breast Cancer Breast Reconstruction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Fat grafting combined with latissimus dorsi muscle flap.
Who it may be relevant to
Registry conditions: Breast Cancer, Breast Reconstruction. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The outcomes of fat grafting combined with latissimus dorsi muscle flap for delayed breast reconstruction after mastectomy

Detailed description

The outcomes of fat grafting combined with latissimus dorsi muscle flap for delayed breast reconstruction after mastectomy

Interventions

  • Procedure Fat grafting combined with latissimus dorsi muscle flap
    Fat grafting combined with latissimus dorsi muscle flap for delayed breast reconstruction

Primary outcome measures

  • Wound infection or dehesiens [Time frame: 2 weeks]

Eligibility criteria

Inclusion criteria

  • female patient indicated for skin sparying mastectomy

Exclusion criteria

  • female patients with stage 4 breast cancer

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Sohag university hospital — Sohag

Identifiers

NCT: NCT07331753 · Soh-Med--25-12-2MD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗